Capping Prescription Costs Act of 2025

Bill 119 HR 2553, also known as the "Prescription Drug Cost Sharing Limitation Act," aims to address the rising costs of prescription drugs by limiting the amount that individuals are required to pay out-of-pocket for their medications. The bill seeks to provide relief to consumers who are struggling to afford necessary medications by capping the amount of cost-sharing that insurance companies can impose.

Under the provisions of the bill, insurance plans would be required to limit the amount that individuals are required to pay for prescription drugs to a certain percentage of the total cost. This would help to prevent individuals from facing exorbitant costs for necessary medications, particularly for those with chronic conditions who rely on multiple prescriptions.

In addition to limiting cost-sharing, the bill also includes provisions aimed at increasing transparency in drug pricing and promoting competition in the pharmaceutical industry. By requiring drug manufacturers to disclose pricing information and encouraging the development of generic alternatives, the bill seeks to lower overall drug costs for consumers. Overall, Bill 119 HR 2553 represents a bipartisan effort to address the growing issue of prescription drug affordability in the United States. By limiting cost-sharing, increasing transparency, and promoting competition, the bill aims to make prescription medications more accessible and affordable for all Americans.